Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis?

Nonalcoholic steatohepatitis (NASH) is a progressed stage of non-alcoholic fatty liver disease, and available therapeutic strategies for NASH are limited. Vitamin D receptor (VDR) is proposed as a druggable target for NASH due to the discovery of vitamin D deficiency in NASH patients. To date, vitam...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ying, Shu, Xiang-Bing, Yao, Zemin, Ji, Guang, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579753/
https://www.ncbi.nlm.nih.gov/pubmed/33132636
http://dx.doi.org/10.3748/wjg.v26.i38.5812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579753/
https://www.ncbi.nlm.nih.gov/pubmed/33132636
http://dx.doi.org/10.3748/wjg.v26.i38.5812

Ejemplares similares